Molecules 2008, 13(12), 3224-3235; doi:10.3390/molecules13123224
Article

A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex)

1 Carl Gustav Carus-Institut, Am Eichhof 30, D-75223 Niefern-Öschlbronn, Germany 2 Betulin-Institut, Blumenstrasse 24, D-64297 Darmstadt, Germany
* Author to whom correspondence should be addressed.
Received: 31 October 2008; in revised form: 10 December 2008 / Accepted: 17 December 2008 / Published: 18 December 2008
(This article belongs to the Special Issue Triterpenes and Triterpenoids)
PDF Full-text Download PDF Full-Text [282 KB, uploaded 18 December 2008 10:45 CET]
Abstract: During the last two decades triterpenes have attracted attention because of their pharmacological potential. Triterpene extract (TE) from outer bark of birch consisting mainly of betulin is able to form an oleogel which was successfully tested in the treatment of actinic keratosis. Some aspects of TE in vitro pharmacology are already known. Now we show preliminary pharmacokinetics of betulin and results of a subchronic toxicity study of TE in rats and dogs. Because of poor aqueous solubility of the TE-triterpenes (< 0.1 μg/mL respectively), for pharmacokinetic studies it was suspended in sesame oil (rats, i.p.) and PEG 400 / 0.9 % NaCl (dogs, s.c.). I.p. administered, betulin, the main component of TE, shows time dependency over a period of 4 h and reaches a dose-independent serum level of 0.13 μg/mL. Dose dependency was observed with s.c. administration. At 300 mg/kg a maximum plasma concentration of 0.33 μg/mL betulin was detected after 28 daily applications. The subchronic toxicity study showed no toxicity of TE in rats (i.p.) and dogs (s.c.). In conclusion, triterpene extract from birch bark is safe, its betulin is bioavailable and in addition to published triterpene biological activities TE provides high potential for further pharmaceutical and pharmacological research.
Keywords: Triterpene extract; Betulin; Preliminary pharmacokinetics; Subchronic toxicity

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Jäger, S.; Laszczyk, M.N.; Scheffler, A. A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex). Molecules 2008, 13, 3224-3235.

AMA Style

Jäger S, Laszczyk MN, Scheffler A. A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex). Molecules. 2008; 13(12):3224-3235.

Chicago/Turabian Style

Jäger, Sebastian; Laszczyk, Melanie N.; Scheffler, Armin. 2008. "A Preliminary Pharmacokinetic Study of Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch (Betulae alba cortex)." Molecules 13, no. 12: 3224-3235.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert